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Abstract
Chronic intermittent hypoxia (IH) induces activation of the sympathoadrenal system, which
plays a pivotal role in attenuating hypoxic pulmonary vasoconstriction (HPV) via central β1-
adrenergic receptors (AR) (brain) and peripheral β2AR (pulmonary arteries). Prolonged
hypercatecholemia has been shown to upregulate β3AR. However, the relationship
between IH and β3AR in the modification of HPV is unknown. It has been observed that
chronic stimulation of β3AR upregulates inducible nitric oxide synthase (iNOS) in cardio-
myocytes and that IH exposure causes expression of iNOS in RAW264.7 macrophages.
iNOS has been shown to have the ability to dilate pulmonary vessels. Hence, we hypothe-
sized that chronic IH activates β3AR/iNOS signaling in pulmonary macrophages, leading to
the promotion of NO secretion and attenuated HPV. Sprague-Dawley rats were exposed to
IH (3-min periods of 4–21%O2) for 8 h/d for 6 weeks. The urinary catecholamine concentra-
tions of IH rats were high compared with those of controls, indicating activation of the sym-
pathoadrenal system following chronic IH. Interestingly, chronic IH induced the migration of
circulating monocytes into the lungs and the predominant increase in the number of pro-
inflammatory pulmonary macrophages. In these macrophages, both β3AR and iNOS were
upregulated and stimulation of the β3AR/iNOS pathway in vitro caused them to promote NO
secretion. Furthermore, in vivo synchrotron radiation microangiography showed that HPV
was significantly attenuated in IH rats and the attenuated HPV was fully restored by block-
ade of β3AR/iNOS pathway or depletion of pulmonary macrophages. These results suggest
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that circulating monocyte-derived pulmonary macrophages attenuate HPV via activation of
β3AR/iNOS signaling in chronic IH.
Introduction
Intermittent hypoxia (IH) during sleep periods is a distinctive feature in the patients of sleep
apnea syndrome (SAS) [1–3]. IH exposure to healthy humans and animals causes prolonged
activation of the sympathoadrenal system and elevation of daytime blood pressure [1, 4–8].
Therefore, IH accompanying sympathoadrenal activation has been implicated in the pathogen-
esis of systemic hypertension caused by SAS [9]. However, the effect of an increase in sym-
pathoadrenergic activity on pulmonary vascular tone is not fully elucidated.
Hypoxic pulmonary vasoconstriction (HPV) is an important mechanism for optimizing
ventilation/perfusion matching [10] and also inducing pulmonary hypertension [2]. In a previ-
ous study, we have reported that the centrally-mediated increase in sympathetic nervous activ-
ity following IH acts to blunt HPV via β1-adrenergic receptors (β1AR) in the brain [11]. In
addition, we have also reported that IH-derived activation of β2AR, not β1AR, in the pulmo-
nary arteries attenuates the HPV [12]. These results demonstrate that IH-derived sympathoa-
drenal activation attenuates HPV via β1AR and β2AR. However, the role of β3AR in modifying
HPV is unknown.
In in vivo and in vitro animal experiments, it has been demonstrated that diseases associated
with prolonged increase in catecholamine levels result in β3AR upregulation in cardiomyocytes
[13–16]. Furthermore, chronic stimulation of β3AR has been shown to induce inducible nitric
oxide synthase (iNOS) overexpression and NO secretion in the mouse heart [17]. It is interest-
ing to note that IH exposure per se increased iNOS expression in RAW264.7 macrophages in
vitro [18]. Moreover, iNOS/NO signaling has the ability to dilate pulmonary vessels during sep-
tic shock [19, 20]. These studies suggest a possibility that iNOS in pulmonary macrophages is
upregulated by chronic IH directly and/or chronic stimulation of β3AR in response to the IH-
induced sympathoadrenal activation to release NO and reduce pulmonary vascular tone. To
the best of our knowledge, however, there has been no report concerning activation of β3AR
and iNOS/NO signaling in pulmonary macrophages following chronic IH.
In this study, we hypothesized that 1) β3AR in the pulmonary macrophages may be upregu-
lated by IH associated with sympathoadrenal activation, 2) iNOS expression in the pulmonary
macrophages may also be increased following stimulation of the upregulated β3AR as well as
directly by IH per se, and 3) the β3AR/iNOS signaling in the pulmonary macrophages may be
activated to release substantial NO in response to acute hypoxic exposure and thus, may mod-
ify HPV. To verify these hypotheses, we performed the following experiments using rats treated
with chronic IH (IH rats) and rats exposed to normoxia (N rats). We first evaluated the expres-
sion of β3AR and iNOS in the pulmonary macrophages using immunohistochemical and elec-
trochemical techniques (i.e. Western blot). Second, we examined whether stimulation of β3AR
on the macrophages promotes iNOS-mediated NO secretion in vitro using bronchioalveolar
lavage (BALF)-derived macrophages. Third, using synchrotron radiation microangiography
for visualizing the pulmonary microvessels in vivo, we revealed the functional contribution of
β3AR/iNOS signaling in the pulmonary macrophages to modulation of HPV.
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Materials and Methods
Animals
Experiments were conducted on 7 wk old male Sprague-Dawley rats. All rats were on a 12:
12-h light-dark cycle at 25°C and were provided with food and water ad libitum. Rats were
divided into two groups. One was housed in normoxic conditions (N rats). The other was con-
tinuously housed in an airtight Plexiglas chamber (27 x 44 x 19 cm, model KYN-370, Biore-
search Center, Tokyo, Japan) with IH exposure for 6 weeks, except for a 10 minute interval
every fifth day when chamber was cleaned (IH rats) [21]. IH treatment consisted of alternating
90 seconds cycles of normoxia (21% O2) and hypoxia (reaching 4% O2 at the nadir). N2 was
delivered to the chamber at a rate of 14 L/min (PSA type N2 generator, ECONOX Ver. 2.10,
ECOTS, Osaka, Japan). Compressed air was delivered at a rate of 54 L/min (Oil free scroll type,
Smart Air SLP-15EBD, ANEST IWATA, Yokohama, Japan). The gas flushing the chamber was
automatically switched from compressed air to N2 and back to compressed air with the use of a
timed solenoid valve. The O2 concentration in the chamber was monitored by an O2 analyzer
(Oxygen monitor JKO-25 Ver. 3, JIKCO, Tokyo, Japan). Exposure was performed 8 hours/day
(9:00 AM—5:00 PM) for 42 consecutive days. All experiments were approved by the Institu-
tional Animal Care and Use Committee of the University of Tokyo.
Sampling of 24-hour Urine Catecholamine
For 24-hour urine collection, N rats and IH rats were housed in metabolic cages (Natsume,
Tokyo, Japan) at the completion of the 6-week IH exposure. The collected urines were consecu-
tively drawn into tubes containing 20 μL of 2.5 mol/L HCl. After urine collection, concentra-
tion of catecholamine was measured using high-performance liquid chromatography method
(SRL Japan, Tokyo, Japan).
Intratracheal Administration of Liposomal Clodronate
Liposomal clodronate was administered into the trachea as previously described [22]. It was
reported previously that the most effective depletion of macrophage was observed after 72 h of
clodronate intratracheal administration (i.t.) [22, 23]. After 6 weeks exposure of IH, a single
dose of liposomal clodronate (Clodrosome, Encapsula NanoSciences, Nashville, TN) was
administered to N and IH rats via the i.t. route 3 days before synchrotron radiation (SR) micro-
angiography. Rats were sedated with pentobarbital (70 mg/kg) intraperitoneally (i.p.). Using
standard aseptic procedures, the tracheas were exposed by surgical resection and pierced with a
26-gauge needle for i.t. injection of 500 μg of clodronate contained in 100 μL saline. The neck
wound was closed with sterile sutures. To confirm that the i.t. injection of clodronate depletes
pulmonary macrophages, the lungs were isolated immediately after clodronate treatment in
another group of N and IH rats. In this case, the reduction in number of macrophages was eval-
uated with immunofluorescent staining using anti-ED-1 antibody (see below).
Chronic Repeated Intravenous Administration of Fluorescent Liposomes
Fluorescent liposomes (Fluoroliposome, Encapsula NanoSciences) were injected via the caudal
vein on -1 day before IH exposure, and injection was performed every week during the 6 weeks
of IH experiment. Each time 0.4 mL of fluorescent liposome contained in 1 mL saline was
injected. Lung and liver tissues were frozen in O.C.T., and sliced into 10-μm sections with a
cryostat. Images of the unfixed cryosections were captured with fluorescence microscopy
BIOREVO BZ-9000 (Keyence, Osaka, Japan). The liver sections were used as a positive control
for circulating monocytes-derived macrophages which engulf fluorescent liposomes.
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Synchrotron Radiation Microangiography
SR pulmonary microangiography was performed as described previously [24]. Each rat was
anesthetized with pentobarbital sodium (70 mg/kg, i.p.) and analgesic agent butorphanol tar-
trate (0.5 mg/kg, i.p.). Supplementary doses of pentobarbital (~15 mg/kg/hr i.p.) and butorpha-
nol tartrate (0.025 mg/kg/hr i.p.) were periodically administered to maintain a surgical level of
anesthesia during microangiography procedure. We used 5-min exposure to 10% O2 to induce
HPV. In this study, 4 types of protocol were performed. 1) To assess the β3AR mediated modi-
fication of HPV, an angiogram during hypoxic exposure was recorded following the baseline
angiogram with room air. These angiograms were repeated after administration of SR59230A
(lipophilic selective β3-blocker, 7.5 mg/kg, i.v., Sigma-Aldrich) in N and IH rats. 2) To assess
β3AR/NOS signaling-mediated pulmonary vasodilation, the angiograms were recorded before
and after acute administration of CL316243 (lipophilic selective β3-agonist, 100 μg/kg, i.v.,
Tocris Bioscience, Ellisville, MO, USA) with/without L-NAME (non-selective NOS blocker,
50 mg/kg, i.v., Sigma-Aldrich) or L-NIL (selective iNOS blocker, 3 mg/kg, i.v., Cayman Chemi-
cal, Ann Arbor, MI). All angiograms in this protocol were taken under ganglion blockade with
hexamethonium bromide (autonomic ganglionic blocker, 25 mg/kg, i.v., Wako, Osaka, Japan)
to exclude the secondary effect of the β3-agonist via central nervous system. 3) To assess the
modification of HPV by iNOS, the angiogram during acute hypoxic exposure was recorded fol-
lowing the baseline angiogram with room air, and these angiograms were repeated after an
administration of L-NIL in N and IH rats. 4) To assess the modification of HPV by IH-derived
accumulated pulmonary macrophage, the angiograms with room air and hypoxic exposure
were recorded in N and IH rats following i.t. administration of liposomal clodronate 3 days
before angiography.
Image Analysis of SR Microangiograms
Image analysis was performed using Image Pro-Plus ver. 4.1 (Media Cybernetics, Silver Spring,
MD) as described previously [24]. The line-profile function of Image Pro-Plus was used as an
accurate method for measuring the internal diameter (ID) of individual vessels. A 50 μm thick
tungsten wire appeared in all recorded images and was used as a reference for calculating vessel
ID. Vessels were categorized according to ID; 100–200 μm, 200–300 μm, 300–500 μm and 500-
μm. The magnitude of HPV was calculated as % change in diameter relative to baseline.
Immunohistochemistry of Lung Sections
Paraffin blocked lungs from N and IH rats were sliced into 5-μm sections and placed onto
clean glass slides. After deparaffinization, the slides soaked in the citrate buffer were heated
with microwave for 5 min for antigen retrieval. Then, the slides were incubated in methanol
with 3% hydrogen peroxide for 10 min to block endogenous peroxidase activity. Nonspecific
protein binding was blocked by treatment with normal bovine serum albumin for 30 min. The
sections were incubated overnight with anti-β3AR antibody (Santa Cruz Biotechnology, Cali-
fornia, CA) at 4°C. The slides were then washed 3 times with PBS and treated with secondary
antibodies for 30 min at room temperature. After washing 3 times, the slides were exposed to
an ABC horseradish peroxidase (HRP) reagent (Vector Laboratories, Burlingame, CA) in PBS
for 30 min. The GFP signal was developed with Peroxidase Substrate Kit AEC (Vector Labora-
tories), and finally the slides were mounted with water soluble mounting medium. The stained
sections were visualized with an Eclipse E400 microscope (Nikon, Tokyo, Japan) attached to a
high-resolution digital camera DXM 1200F (Nikon). Images were captured with ACT-1 soft-
ware (Nikon).
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Quantitative Analysis of Pulmonary Arteries
Quantitative image analysis of immunohistochemical stained sections with anti-β3AR antibody
was performed with Image Pro-Plus ver. 4.1 software as described previously [2, 25]. The red
stain was selected semi-automatically. Optical density and area of the red stain were obtained.
Quantification of the expression level of the protein was estimated as expression level score
(ELS): ELS = (mean optical density of positively stained area–mean optical density of back-
ground area) x percent area of positively stained.
Immunofluorescence Microscopy of Lung Sections
After deparaffinization, the lung sections were soaked in the citrate buffer and heated with
microwave for 5 min. Blocking was performed with bovine serum albumin for 30 min. The sec-
tions were exposed to primary antibody overnight followed by appropriate secondary antibody
for 60 min. The staining was imaged with fluorescence microscopy BIOREVO BZ-9000 (Key-
ence). Using primary antibodies were anti-ED1 (CD68) antibody (AbD Serotec, Oxford, UK)
and anti-β3AR antibody (Santa Cruz Biotechnology).
Bronchioalveolar Lavage
After 6 weeks of IH exposure, N and IH rats were sacrificed by single i.p. injection of pentobar-
bital and subsequent exsanguination via the abdominal aorta. The trachea was cannulated and
bronchoalveolar lavage (BAL) was performed in situ by infusing the lungs with 5 mL aliquots
of PBS. The BAL fluid (BALF) was drained passively by gravity and the procedure was repeated
four times, giving a total BALF volume of 20 mL.
Positive Control for Pro-inflammatory Macrophage
Pulmonary macrophages obtained from LPS administered rats were used as positive controls
for pro-inflammatory macrophages. Rats were sedated by inhalation of 3% isoflurane. BALF
was obtained for gathering pulmonary macrophages 24 hours after i.p. administration of LPS
(10 mg/kg), after sacrificing the rats by bleeding from the abdominal aorta.
Immunocytochemistry of Pulmonary Macrophages
BALF obtained from LPS-administered rat, N rats, and IH rats was centrifuged at 500 g for
10 min (Kubota 1720, Tokyo, Japan). Two mL of saline was added to the precipitate of BALF
and mixed softly. One hundred μL of each solution was dropped onto the slides and dried over-
night. The slides were fixed with cold 50% acetone in methanol for 10 min and washed three
times with PBS for 5 min. They were then incubated with 1% Triton X-100 for 10 min. After
being washed thrice with PBS for 5 min, the slides were blocked with bovine serum albumin
for 30 min and incubated with primary antibodies overnight at 4°C. The slides were washed
three times with PBS for 5 min. After incubation with fluorescent conjugated secondary anti-
bodies, images were captured with a fluorescence microscopy BIOREVO BZ-9000 (Keyence).
The primary antibodies used were anti-ED1(CD68) antibody (AbD Serotec), anti-iNOS anti-
body (Thermo Fisher Scientific, Waltham, MA), anti-eNOS antibody (Enzo Life Sciences,
Farmingdale, NY), anti-nNOS antibody (Enzo Life Sciences), anti-CD11c antibody (AbD Sero-
tec), anti-IL-6 antibody (R&D Systems, Minneapolis, MN), and anti-β3AR antibody (Santa
Cruz Biotechnology).
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Positive Cell Counting in Immunofluorescent Images
For assessment of macrophage infiltration and β3AR upregulation, ED1 and β3AR positive cell
counting was performed in the immunofluorescent images of lung sections. Ten representative
images (200 x) were chosen from the left lobe of each animal. The number of stain positive
cells was counted automatically by Image Pro Plus ver. 4.1 (Media Cybernetics).
Nitrite Measurement of Macrophage Cultures
BALF obtained from N and IH rats were centrifuged at 500 g for 10 min (Kubota 1720, Tokyo,
Japan). The pellet was resuspended in phenol red free RPMI 1640 medium (Gibco Laborato-
ries, Grand Island, NY) with 1% streptomycin at 1.4 x 105 cells / mL. The cells were plated at
4.2 x 105 macrophages per well in polystyrene tissue culture plates and allowed to adhere for
12 h at 37°C in an atmosphere of 5% CO2 / 95% O2. Then, 100 μM of CL316243 (Tocris Biosci-
ence), 100 μM of isoproterenol (LKT Laboratories, Minneapolis, MN), and 100 μM of
CL316243 + 50 μM of L-NIL (Cayman Chemical) were administered. After incubation for 30 h
at 37°C, the media were ultrafiltered at 7000 g x 20 min with ultracentrifugal filter units for
10 kD molecules (EMDMillipore, Billerica, MA). NO levels in the cell-free supernatant were
determined by analysis of its relative stable metabolite nitrite using the Griess reaction with a
fluorometric NO2/NO3 Assay Kit-FX (Dojindo Laboratories, Tokyo, Japan).
Western blot analyses
Frozen lung tissue 0.1 g was homogenized with 1 mL of ice-cold RIPA buffer containing 0.1%
SDS, 0.5% DOC, 1% NP-40, 150 mMNaCl, 50 mM Tris-Cl pH 7.4, 50 mMNaF, 1 mM
Na3VO4 and Complete Protease Inhibitor Cocktail (Roche Diagnostics, Mannheim, Germany).
To remove debris, the homogenate was centrifuged at 1500 g for 5 min, and supernatant was
used for analysis, and the rest was frozen at -80°C. For direct detection of protein expression in
macrophage, BALF obtained from N and IH-rats was centrifuged at 500 g for 5 min and 1 mL
of RIPA buffer was added to the pellet. The macrophage suspension was sonicated sufficiently
and centrifuged at 1000 g for 5 min to remove debris. The homogenized samples of lung and
macrophage were heated at 95°C for 5 min, and 3 x Laemmli buffer containing 9% mercap-
toethanol added. The supernatant was used for analysis and the rest was stored at -80°C. The
protein concentration of homogenates was determined by the Bradford assay. The homogenate
was subjected to SDS-PAGE on a 4–20% gradient precast gel, and separated protein was then
transferred to polyvinylidene fluoride (PVDF) membranes using a transfer system Trans Blot
Turbo (BioRad, Tokyo, Japan). Nonspecific antibody binding was blocked using 3% skim milk
in TBS-T 0.1%, and the membranes were incubated with primary antibodies. The signals were
detected by a luminescent image analyzer Image Quant Las 4000 mini (GE Healthcare, Wauke-
sha, WI) using a secondary antibody coupled to horseradish peroxidase (Promega, Madison,
WI). Primary antibodies used were anti-β3AR (Santa Cruz Biotechnology), anti-iNOS antibody
(Abcam), anti-eNOS antibody (Enzo Life Sciences, Farmingdale), anti-nNOS antibody (Enzo
Life Sciences), anti-IL-6 antibody (R&D Systems), and anti-TNFα antibody (Abcam).
RT-PCR analysis
Lung tissue samples were homogenized and used for RNA isolation using ISOGEN (Nippon
Gene, Tokyo, Japan). The purified RNA was then reverse transcribed using TaqMan Reverse
Transcription Reagents (Applied Biosystems Japan, Tokyo, Japan). Expression levels of mRNA
of β3AR were assayed quantitatively by real-time RT-PCR using TaqMan Gene Expression
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Assays (Applied Biosystems Japan). Quantitative mRNA expression data were acquired and
analyzed by 7000 Sequence Detection System (Applied Biosystems Japan).
Statistical analysis
All statistical analyses were conducted using GraphPad Prism6 (GraphPad Software, San
Diego, CA). The results of relative expression of β3AR mRNA and % change in internal diame-
ter in SR angiograms are presented as mean ± standard error of the mean (S.E.M.) and the data
analysis was performed using Student’s t-test (unpaired) or two-way ANOVA with Sidak’s
multiple comparison tests. All other data are presented as mean ± standard deviation (S.D.)
and the data analyses were performed using Student’s t-test (unpaired) or one-way ANOVA
with Tukey’s multiple comparison tests. A P value of< 0.05 was predetermined as the level of
significance for all statistical analysis.
Results
IH induces macrophage accumulation and upregulated β3AR
expression in the lungs
At first, to confirm the activation of the sympathoadrenal system in IH, the rats’ urinary con-
centrations of dopamine, adrenaline, and noradrenaline were measured. Urine was collected
from N and IH rats over 24 hours in normoxic conditions on the day after the last day of IH
exposure. The concentrations of these catecholamines were significantly higher in IH rats than
in N rats (S1 Fig).
Immunofluorescent staining of pulmonary tissue performed after 6 weeks of IH exposure
demonstrated that the number of pulmonary macrophages was significantly increased and the
positive ratio of β3AR-expressing cells was high (Fig 1A–1D). The number of macrophages in
the alveolar space was increased (S2 Fig). Immunocytochemistry showed that β3AR was
strongly expressed in BALF-derived alveolar macrophages from IH rats (Fig 1E). In IH rats,
macrophages accumulated around the small pulmonary arteries and these perivascular macro-
phages also expressed β3AR (Fig 1A, S3 Fig). Western blotting and RT-PCR showed that the
β3AR was expressed in both the lung tissue and BALF-derived alveolar macrophages of N rats
(Fig 1F–1H), and immunohistochemistry demonstrated that the β3AR was expressed on the
endothelium of the pulmonary arteries (S4A Fig). IH significantly increased the protein and
mRNA expression levels of β3AR in the lung tissues (Fig 1F and 1G). The β3AR protein expres-
sion was also elevated in the BALF-derived alveolar macrophages (Fig 1H). In contrast, IH
decreased the expression level of β3AR in the pulmonary arterial endothelium of vessels with
diameters ranging from 50 to 150 μm (S4B Fig). These results indicate that β3AR expression
was upregulated in macrophages but not in the pulmonary arteries in IH rats.
To identify the origin of accumulated macrophages in the lungs of IH, intravenous adminis-
tration of fluorescent liposomes was performed during IH experiments. The results of this
study demonstrate that the increase in the number of pulmonary macrophages induced by IH
stems from the migration of circulating monocytes into the lungs (S5A Fig). As a positive con-
trol, the liver was used for observation of fluorescent liposome engulfed monocytes. Interest-
ingly, IH-induced accumulation of macrophages was also observed in the liver (S5B Fig).
Pulmonary macrophages in IH rats expressed pro-inflammatory markers
including iNOS
To characterize the phenotype of pulmonary macrophages in the lungs of IH, immunocyto-
chemical staining and western blotting were performed using iNOS, CD11c, and IL-6. LPS
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administered rats were used for a positive control of inflammatory macrophages (S6 Fig). Pro-
inflammatory markers such as iNOS, CD11c, and IL-6 were detected in IH rat macrophages,
but not those of N rats (Fig 2A). Western blotting demonstrated that the protein expression
levels of pro-inflammatory markers; i.e., iNOS, IL-6, and TNFα were significantly upregulated
in IH-induced macrophages (Fig 2B). These results indicated that the IH stimulation promoted
differentiation of the pulmonary macrophages into a pro-inflammatory type.
Pulmonary macrophages release NO via the β3AR/iNOS pathway in IH
rats
To assess the NO synthesis ability of pulmonary macrophages, BALF-derived macrophages
were used for in vitro experiments. In groups without drug administration, the total amount of
the macrophage-derived nitrite (chemically stable metabolite of NO) was not different between
N and IH rats. In the pulmonary macrophages obtained from IH rats, but not N rats, the
administration of the β3-agonist CL316243 enhanced the secretion of nitrite, which is indica-
tive of elevated NO synthesis and release (Fig 3). The increase in nitrite synthesis induced by
CL316243 was prevented by the simultaneous administration of the iNOS blocker L-NIL. In
contrast, the non-selective β1 and β2-agonist isoproterenol decreased nitrite synthesis in both
N and IH rats. These results suggest that NO secretion was facilitated in the IH-derived pro-
inflammatory macrophages by the activation of β3AR/iNOS signaling, but not by β1 or β2AR
activation.
HPV is markedly attenuated in IH rats
The degree of HPV was estimated using synchrotron radiation microangiography. In N rats,
acute hypoxic exposure (10% O2) induced marked constriction (HPV) in the small pulmonary
arteries with internal diameters (ID) of 100–500 μm, but not in those with ID of more than
500 μm (Fig 4A and 4B). The extent of the HPV (% reduction in ID caused by acute hypoxia)
tended to increase as arterial diameter decreased, with the greatest degree of constriction
(approximately 24%) occurring in the arteries with ID of between 200 and 300 μm. In IH rats,
acute hypoxic exposure only induced significant HPV in the pulmonary vessels with ID of
200–300 μm, and the degree of HPV was approximately half of that seen in N rats (Fig 4B),
indicating that the HPV induced by acute hypoxic exposure was greatly attenuated in IH rats.
β3AR activation causes iNOS-dependent vasodilation and attenuates
HPV in IH
In IH rats, SR59230A, a lipophilic selective β3-blocker, restored the attenuated HPV to almost
the same level as was seen in N rats (Fig 4A and 4C). In contrast, SR59230A had no significant
effect on the HPV seen in N rats. Pretreatment with the selective iNOS inhibitor L-NIL also
Fig 1. IH causes the accumulation of macrophages and upregulates β3AR expression in the lungs. (A)
Representative bright-field images of lung sections from the N and IH rats and images of immunofluorescent
staining of such sections with anti-ED-1 antibody, anti-β3AR antibody, or both (merged images). Calibration
bar = 200 μm for 40 x, 50 μm for 200 x. (B, C) The numbers of ED-1- and β3AR-positive cells per field (200 x)
were counted using Image Pro Plus ver. 4.1 (n = 6 each, mean ± S.D.) (D) Ratio of the percentage of β3AR-
positive cells to the percentage of ED-1-positive cells (n = 6 each, mean ± S.D.) (E) Representative images of
double immunocytochemical staining using anti-ED-1 and β3AR antibody in BALF-derived macrophages.
Calibration bar = 50 μm. (F) Western blot analysis of β3AR in lung homogenate solutions from the N and IH
rats (n = 6 each, mean ± S.D.) (G) The expression level of β3ARmRNA in lung tissue samples from the N and
IH rats (n = 6 each, mean ± S.E.M.) (H) Western blot analysis of β3AR in BALF-derived pulmonary
macrophages obtained after 6 weeks of IH or normoxic exposure (n = 5 each, mean ± S.D.) *Significant
difference between the N and IH rats (*P<0.05, **P<0.01).
doi:10.1371/journal.pone.0131923.g001
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Fig 2. Pulmonary macrophages in IH rats expressed pro-inflammatory markers including iNOS. The pulmonary macrophages were obtained from
BALF after 6 weeks of IH or normoxic exposure. (A) Immunocytochemical staining of pro-inflammatory markers iNOS, CD11c, and IL-6 was performed. (B)
Western blot analysis of iNOS, IL-6, and TNFα in BALF-derived macrophages (n = 5 each, mean ± S.D.). *Significant difference between the N and IH rats
(*P<0.05).
doi:10.1371/journal.pone.0131923.g002
Fig 3. Pulmonary M1macrophages release NO after activation of the β3AR/iNOS pathway in IH rats.
Nitrite synthesis from BALF-derived pulmonary macrophages that had been treated with or without
CL316243 (CL), isoproterenol (ISO), and CL+L-NIL. A quantitative analysis of nitrite secretion was performed
30 hours after the addition of the drugs using the Griess reaction. The number of rats in each group is shown
within each column. Data are presented as mean ± S.D. values.
doi:10.1371/journal.pone.0131923.g003
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restored the attenuated HPV in the same manner as SR59230A (Fig 5). These results suggest
that IH activates both a β3AR-mediated and iNOS-mediated vasodilatory mechanism to atten-
uate HPV.
To assess whether peripheral β3AR, but not the β3AR in the central nervous system, contrib-
ute to HPV attenuation in IH, CL316243 was administered under ganglionic blockade with
hexamethonium bromide. In IH rats, CL316243 induced extensive dilatation of the small pul-
monary arteries, particularly in the arteries with ID of 100–500 μm (Fig 6A and 6B). In con-
trast, CL316243 had no significant effect in N rats. These results indicate that peripheral β3AR
were activated to a much greater extent in IH rats than in N rats, and strongly suggest that
peripheral β3AR contributed to the HPV attenuation observed in IH rats.
Next, we investigated whether NOS is involved in the β3AR-mediated pulmonary vasodila-
tion observed in IH rats. Pretreatment with L-NAME or L-NIL completely abrogated the
CL316243-mediated pulmonary vasodilation in IH rats (Fig 6A, 6C and 6D). There was no sig-
nificant difference in the strength of the inhibitory effect between L-NAME and L-NIL. These
results suggest that iNOS-derived NO was chiefly responsible for the β3AR-induced pulmonary
Fig 4. Blockade of β3AR completely restores attenuated HPV in IH rats. (A) Representative
microangiographic images showing the branching pattern of the small pulmonary arteries during normoxia and
in response to hypoxia with or without SR59230A (selective β3-blocker). Images were recorded after 5 min
exposure to A: normoxia, B: hypoxia (10%O2), C: SR59230A + normoxia, and D: SR59230A + hypoxia in the
same lung field. The black arrows point to branches of the pulmonary arteries that constricted in response to
acute hypoxia. The tungsten wire in the lower right corner of each image is a reference wire with a diameter of
50 μm. (B, C) Relationship between vessel size and the extent of the pulmonary vasoconstriction (% decrease
in vessel diameter) induced in response to acute hypoxia in the N and IH rats treated with or without SR59230A.
The data are presented asmean ± S.E.M. values. *Significant reduction in vessel diameter compared with the
normoxic conditions (**P<0.01). †Significant difference between the N and IH rats (††P<0.01). ‡Significant
difference compared with the no drug conditions. (‡‡P<0.01).
doi:10.1371/journal.pone.0131923.g004
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vasodilation observed in IH rats. Taken together, these observations strongly suggest that the
β3AR/iNOS pathway is activated in IH, resulting in the dilation of pulmonary arteries and the
attenuation of HPV.
Acute intra-tracheal administration of clodronate restores HPV in IH rats
To investigate whether the macrophages that accumulated in the lungs of the IH rats contrib-
uted to the observed HPV attenuation, HPV was evaluated in pulmonary macrophage depleted
rats using microangiography. Clodronate was administered into the lungs of IH rats via the tra-
chea immediately after the 6-week IH exposure period. Clodronate strongly suppressed the
number of pulmonary macrophages in IH rats to the control level (Fig 7A) and enhanced the
attenuated HPV to almost the same level as that seen in N rats (Fig 7B and 7C). These results
indicate that the intra-alveolar macrophages that accumulate in the lungs in IH contribute to
the attenuation of HPV.
Discussion
The present study demonstrated that 1) chronic IH increases pro-inflammatory macrophages
with upregulation of β3AR and iNOS in the lungs, 2) IH-derived activation of β3AR/iNOS
Fig 5. Blockade of iNOS completely restores attenuated HPV in IH rats. (A) Representative images of the
branching pattern of the small pulmonary arteries at the baseline and after the administration of L-NIL
(selective iNOS inhibitor). The black arrows point to constricted pulmonary arteries. (B, C) Relationship
between vessel size and the extent of the pulmonary vasoconstriction induced in response to acute hypoxia
with or without selective L-NIL treatment. Data are presented as mean ± S.E.M. values. *Significant change
in vessel diameter compared with the baseline conditions (**P<0.01). †Significant difference between the N
and IH rats (†P<0.05; ††P<0.01). ‡Significant difference compared with the no drug conditions (‡P<0.05,
‡‡P<0.01).
doi:10.1371/journal.pone.0131923.g005
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signaling promotes NO secretion from pulmonary macrophages, and 3) that the pulmonary
macrophages attenuate HPV via the β3AR/iNOS signaling pathway in IH rats.
We first confirmed that activation of sympathoadrenal system persists even after chronic IH
exposure. Because the 24-hour collection of urine was performed while the rats were main-
tained in a normoxic atmosphere on the day after the last day of IH exposure, the results of uri-
nary concentrations indicate that the sympathoadrenal system is persistently activated in IH
rats even after their release from chronic IH. These results are consistent with the findings of
previous reports [8, 11, 26].
The present angiographic data showed that in N rats, HPV occurs in the small pulmonary
arteries of 100–500 μm ID with a maximum constriction in the 200–300 μm range. This ID-
dependent vasoconstriction pattern is consistent with our previous reports [11, 12, 27]. HPV
was significantly attenuated in the arteries with ID ranging between 100–500 μm and signifi-
cant HPV was observed only in the arteries of 200–300 μm ID following IH-induced sym-
pathoadrenal activation. This result is also consistent with our previous report [11, 12]. The
present study has revealed that this attenuation of HPV is abrogated by β3AR blockade. Fur-
ther, after chemical blocking of the sympathetic nerve with a ganglion blocker, stimulation of
β3AR induced significant dilation in the small pulmonary arteries in IH rats, but not in N rats.
Collectively, these results suggest that in IH, peripheral β3AR which are distributed within the
lungs are activated by increased sympathoadrenal activity, causing the decrease in pulmonary
vascular tone and attenuation of HPV.
Fig 6. Stimulation of β3AR dilates pulmonary arteries via iNOS-dependent signaling in IH rats. (A)
Representative microangiographic images showing the branching pattern of the small pulmonary arteries at
the baseline and after the administration of each drug. The white arrows point to branches of dilated
pulmonary arteries or small pulmonary arteries that were first detected after the administration of CL316243
(a selective β3-agonist). The tungsten wire in the lower right corner of each image is a reference wire that
measures 50 μm in diameter. (B) Extent of the change in vessel diameter induced in response to the
administration of CL316243 with pretreatment of hexamethonium bromide (C6) in the N and IH rats. Data are
presented as mean ± S.E.M. values. *Significant change in vessel diameter compared with the baseline
conditions (*P<0.05; **P<0.01). †Significant difference between the N and IH rats (†P<0.05; ††P<0.01). (C,
D) Percentage change in the mean diameter of small pulmonary arteries in response to the administration of
CL316243 after pretreatment of with either L-NAME or L-NIL. Data are presented as mean ± S.E.M. values.
doi:10.1371/journal.pone.0131923.g006
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In N rats, β3AR was observed in the endothelium of the small pulmonary arteries; however,
β3-agonist had no significant vasodilatory effect on these vessels. This is consistent with the
findings of previous studies in which β3AR had no [28, 29] or only weak vasodilatory capacity
in normoxic pulmonary vessels [30, 31]. In addition, we showed that the β3AR expression in
the small pulmonary arteries is decreased in IH rats. Collectively, pulmonary vascular β3AR are
likely to play a minimal role in controlling vascular tone in IH. In contrast, we showed that the
β3AR expression on the alveolar and the perivascular macrophages is significantly elevated in
IH rats. Moreover, the depletion of intra-alveolar macrophages restored the normal level of
HPV in IH rats. These results suggest that the β3AR expressed on the more abundant ‘alveolar’
macrophages contribute to attenuation of HPV in IH rats. In the present study, it was not eluci-
dated whether the ‘perivascular’macrophages contributed to attenuation of HPV in the same
manner as alveolar macrophages. The high expression of the β3AR in the perivascular macro-
phages implicates their contribution to HPV modification, although future research is essential
to resolve this question.
Fig 7. Acute intratracheal administration of clodronate restores HPV in IH rats. (A) Representative
bright-field images and images of immunofluorescent staining using anti-ED-1 antibody of lung sections with
or without clodronate. Clodronate (500 μg of clodronate in 100 μL of saline) was injected intratracheally just
after the end of the 6-week IH/normoxia exposure period. Calibration bar = 200 μm. (B) Representative
microangiographic images of the small pulmonary arteries in the N and IH rats obtained 3 days after the i.t.
administration of clodronate. The black arrows point to branches that underwent vasoconstriction. (C)
Relationship between vessel size and the extent of the pulmonary vasoconstriction induced in response to
acute hypoxia. Data are presented as mean ± S.E.M. values. *Significant change in vessel diameter
compared with the baseline conditions (**P<0.01).
doi:10.1371/journal.pone.0131923.g007
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Several subsets of macrophages with distinct functions have been described. M1 macro-
phages promote inflammation to defend the host from a variety of foreign bodies. M2 macro-
phages have anti-inflammatory functions and regulate wound healing [32]. Previously,
accumulation of macrophages in the lungs [33] and around the pulmonary arteries [34] has
been reported in chronic hypoxic experiments. Frid et al. showed that monocyte-derived mac-
rophage infiltration/accumulation in the adventitia of pulmonary arteries was observed after
4 weeks of chronic hypobaric hypoxia (380 mmHg) in rats [34]. Vergadi et al. showed that
accumulation of macrophages in the lungs was observed from 2 days of chronic hypoxia in the
mouse, and a significant increase in the number of macrophages maintained throughout the
2 weeks of a hypoxic experiment period [33]. Importantly, these macrophages accumulating
with chronic hypoxia-induction were M2 type. In our experiments, accumulation of macro-
phages in the lungs was observed after 6 weeks of IH exposure. The alveolar macrophages
expressed pro-inflammatory proteins such as iNOS, CD11c, and IL-6, suggesting that these
macrophages were M1 type. However, to elucidate the phenotype of these macrophages, more
detail evaluation including characterization of their gene expression profile is needed. Taken
together, the present data indicate that the IH-derived stimulation of β3AR promoted differen-
tiation of the pulmonary macrophages into a pro-inflammatory type with expression of iNOS.
Thus, IH and chronic hypoxia have different effects on the polarization of macrophages. More-
over, chronic intravenous administration of fluorescent liposomes demonstrated that IH
induced the migration of circulating monocytes into the lungs. However, the detailed mecha-
nisms responsible for migration of the circulating monocytes are not revealed in the present
study. Since the migration ability of circulating monocytes into the local peripheral tissues
depends on the expression level of chemokine/chemoreceptors [35], further study is needed to
elucidate the migration mechanism of monocytes into the lungs due to chronic IH exposure.
In the present in vitro study, we demonstrated that β3AR stimulation increased NO secre-
tion via iNOS activation in IH pulmonary macrophages, but not in N macrophages (Fig 3). In
cardiomyocytes, all subtypes of NOS; i.e., eNOS, nNOS, and iNOS, were reported to be down-
stream of β3AR signaling [17, 36–39]. Most of these studies detected significant correlations
between β3AR and eNOS expression. To the best of our knowledge, there has been only one
report about the relationship between β3AR and iNOS [17]. In the present study, eNOS was
detected in the alveolar macrophages (S7A Fig); however, the protein expression level of eNOS
did not differ between IH and N rats (S7B Fig). eNOS expressed on unactivated macrophages
is known to secrete a small amount of NO continuously [40]. Therefore, in the present in vitro
study, the baseline level of nitrite secretion from the macrophages in the absence of drug treat-
ment probably originated from eNOS in both N and IH rats. On the other hand, iNOS
expressed in IH-derived macrophages is suggested as the most dominant physiologically rele-
vant source of NO from the macrophages [41]. Additionally, this previous report revealed that
macrophage-derived NO directly dilates femoral arterial rings in ex vivo experiments [42].
Therefore, considering these findings and our results for angiography (Figs 4–7), it is strongly
indicated that pro-inflammatory macrophages attenuate the HPV via β3AR/iNOS pathway-
derived NO secretion.
In contrast to the results of selective β3AR stimulation, isoproterenol inhibited NO secretion
in both N and IH macrophages. This result is consistent with a previous report in which cate-
cholamines inhibited the macrophage-mediated production of NO through β1 and β2AR in
vitro [43, 44]. Recently, it has been revealed that phosphorylation sites for protein kinase A and
βAR kinase are found in the β1 and β2AR, whereas the β3AR lacks these sites. Thus, the β1 and
β2AR undergo functional desensitization after long-term exposure to hypercatecholemia. In
contrast, sustained stimulation of the β3AR does not modify its functional effects [45–47]. In
the present study, function of the β1 and β2AR on the pulmonary macrophages was not
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disrupted after 6 weeks of IH exposure, however, there is a possibility that much longer expo-
sure of IH than 6 weeks decreases the inhibitory effects of NO production from the macro-
phages. Accordingly, we suggest that β3AR signaling probably plays a pivotal role in
controlling the pulmonary circulation in the pathogenesis accompanying prolonged sym-
pathoadrenergic activation such as chronic IH.
In our previous study, the β2AR dependent activation of PI3kinase/Akt/eNOS signaling in
the pulmonary arteries attenuated the HPV, leading to the prevention of the progression of
pulmonary arterial hypertension (PAH) [12]. Interestingly, blockade of β2AR and β3AR exacer-
bated HPV in IH rats to the same degree as that in control rats. These findings suggest that
both β2AR and β3AR have critical contribution to attenuate HPV in IH. Taking these findings
into consideration, the β3AR/iNOS pathway in pro-inflammatory macrophages presumably
behave in the same manner as the β2AR/eNOS pathway in pulmonary arteries to prevent PAH
progression in IH. To confirm this hypothesis, further research is required.
In SAS patients, PaCO2 is increased due to obstruction of the upper airway during sleeping
periods [9]. The effect of PaCO2 on the pulmonary vascular function in SAS has not been eluci-
dated, however it has been reported that supplementation of CO2 significantly attenuates HPV
in rat [48, 49]. Therefore, there is a possibility that hypercapnia attenuates IH-induced HPV.
To elucidate an effect of blood CO2 on HPV, additional experiments utilising simultaneous
exposure of intermittent hypoxia and hypercapnia are needed. The present study is important
with respect to focus on the effect of intermittent hypoxia to pulmonary hemodynamics, which
is one of the major factors in the pathophysiology in SAS.
In summary, we demonstrate that pro-inflammatory pulmonary macrophages attenuate
HPV via the activation of β3AR/iNOS signaling in IH rats. The relationship between IH-
induced sympathoadrenal activation and pulmonary circulation is not fully elucidated,
although, this study highlights the pivotal role of sympathoadrenal activation and pro-inflam-
matory macrophages in attenuating the HPV in IH. Moreover, we also highlight the impor-
tance of β3AR/iNOS signaling pathway in the preservation of the pulmonary circulation under
prolonged IH exposure.
Supporting Information
S1 Fig. The mean urinary catecholamine concentrations of the IH rats were extremely high
compared with those of the control rats. The concentrations of dopamine, adrenaline, and
noradrenaline in 24-hour urine samples from N and IH rats (n = 5 each). Urine was collected
over 24 hours using metabolic cages under a normoxic atmosphere on the day after the end of
a 6-week period of normoxic or intermittent hypoxic exposure. The data are presented as
mean ± S.D. values. Significant difference between the N and IH rats (P<0.01).
(TIF)
S2 Fig. An increase in the number of macrophages is observed in alveolar spaces. Represen-
tative images of immunohistochemical staining with anti-β3AR antibody in paraffin embedded
lung sections. (A) Almost all intra-alveolar cells in IH rats were strongly stained by anti-β3AR
antibody. In contrast, these cells in N rats were not. These results suggest that the brown
cells are macrophages. Nuclei were counterstained with Haematoxylin. Calibration
bar = 10 μm. (B) These images show the distribution of macrophages in alveolar spaces.
Calibration bar = 50 μm. (C) The number of macrophages in alveolar spaces were significantly
increased in IH rats compared to these in N rats (n = 6 each, mean ± S.D.). Significant differ-
ence between N and IH rats (P<0.01).
(TIF)
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S3 Fig. Macrophages accumulated around a small pulmonary artery. Representative image
of immunohistochemical staining with anti-β3AR antibody in a paraffin embedded lung sec-
tions. Anti-β3AR antibody stained macrophages were accumulated around a small pulmonary
vessel in an IH-treated rat. Calibration bar = 20 μm.
(TIF)
S4 Fig. Expression of β3AR is downregulated in pulmonary arteries. (A) Representative
images of immunohistochemical staining with anti-β3AR antibody in small pulmonary arteries.
Calibration bar = 20 μm. (B) Relative expression level of β3AR protein in small pulmonary
arteries with the diameter range of 50 to 150 μm (n = 6 each, mean ± S.D.). Quantification of
the expression level of the protein was estimated as expression level score (ELS): ELS = (mean
optical density of positively stained area–mean optical density of background area) x percent
area of positively stained. Significant difference between N and IH rats (P<0.05, P<0.01).
(TIF)
S5 Fig. IH induces the accumulation of circulating monocytes in the lung and the liver.
Fluorescent liposomes were administered intermittently (once every 4 days) during the 6
weeks of experiments. (A) Circulating monocytes accumulated in the lungs of IH rats. (B) The
images of liver were used for a positive control for circulating monocyte-derived macrophages.
Calibration bar = 200 μm.
(TIF)
S6 Fig. Immunocytochemical staining of pro-inflammatory markers in BALF-derived pul-
monary macrophages obtained from LPS-administered rats. BALF-derived pulmonary mac-
rophages obtained from LPS (10 mg/kg, i.p., 24h) treated rats were used as positive controls for
pro-inflammatory macrophages. Immunocytochemical staining of iNOS, CD11c, and IL-6 was
performed. Calibration bar = 50 μm.
(TIF)
S7 Fig. eNOS and nNOS are not upregulated in BALF-derived macrophages in IH rats. (A)
Representative images of double immunocytochemical staining with anti-ED-1, and eNOS or
nNOS antibody in BALF-derived macrophages. Calibration bar = 50 μm. (B) Western blot
analysis of eNOS in BALF-derived macrophages (n = 5 each, mean ± S.D.) nNOS was unde-
tectable in both N and IH rats.
(TIF)
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